InvestorsHub Logo
Followers 830
Posts 119741
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 12768

Sunday, 08/17/2008 12:20:28 AM

Sunday, August 17, 2008 12:20:28 AM

Post# of 19309
Auxiliary Reference List of Antithrombin Papers

[Added Cuomo abstract.]


Cardiovascular/stroke
#msg-31305782 AT reduces ischemic volume (Cuomo)
#msg-30287557 Elevation of AT in arteriosclerosis
#msg-29955598 Coronary revascularization
#msg-27074358 Acquired AT deficiency increases risk
#msg-25952778 AT treatment after cardiac surgery
#msg-24268577 Stroke (preclinical)
#msg-13345041 Thrombin increases cardiomyocyte death


DIC / Sepsis
(A separate post accessible from the ‘ReadMeFirst’
contains the primary scientific support for ATryn in
DIC/sepsis, including analysis of the KyberSept study.)

#msg-29423778 AT MoA in sepsis (full paper)
#msg-27419164 How the ISTH DIC score is calculated
#msg-27215812 Scripps paper on sepsis MoA
#msg-29874443 AT works best in medium-risk patients
#msg-26018349 Animal model of gram-positive septicemia
#msg-25907502 Pct of sepsis patients with DIC
#msg-25907331 Hemostatic changes
#msg-25511473 Ditto
#msg-25480768 Anti-inflammatory MoA
#msg-24523875 AT experience in ICU
#msg-24518865 SIRS
#msg-23829730 Animal model
#msg-14277430 Thrombomodulin in DIC
#msg-29874324 Meta-analysis
#msg-13512229 Meta-analysis
#msg-13150691 Animal model
#msg-13102302 Review re AT and APC
#msg-12975208 AT level has predictive value
#msg-12960346 Coagulation vs inflammation pathways
#msg-12743571 Animal model
#msg-12681781 ISTH score for DIC
#msg-11211288 Animal model of AT with tPA
#msg-10232620 Hemostatic changes
#msg-8452794 Reduction of D-dimer levels
#msg-7268415 ATryn itself effective in small study


Adverse outcomes during pregnancy
#msg-26421404 Severe pre-eclampsia
#msg-25630072 DVT
#msg-22037334
#msg-9327646
#msg-8988372
#msg-8256536
#msg-7834418
#msg-7050226


Hereditary deficiency
#msg-25630072 DVT rate (acute)
#msg-24140012 Lovenox doesn’t work in HD
#msg-6794514 DVT rate (chronic)


Cancer
#msg-18991235 Pediatric ALL
#msg-12476761 Coagulation in cancer
#msg-12181584 Acute lymphoblastic leukemia
#msg-11804544 Use of anti-thrombotics in cancer
#msg-9460320 Liver mets in colon cancer
AT fragment in lung-cancer model


Chemistry and pharmacokinetics
#msg-13173404 Covalent linkage between AT and heparin
#msg-12100172 PK of AT from CHO cells
#msg-11801772 PK of ATryn vs plasma AT
#msg-30027881 Ditto
#msg-7669971 AT glycosylation
#msg-6995560 AT glycosylation


Miscellaneous
#msg-30028400 Human nephrotic syndrome
#msg-28267133 VOD
#msg-27074306 FVIII deficiency
#msg-26018345 Burns
#msg-25590840 Increasing AT yield from CHO cells
#msg-25481215 Acute lung injury (preclinical)
#msg-25291011 Ditto
#msg-20210837 ARDS
#msg-15039853 Burns
#msg-14277297 Polymicrobial peritonitis
#msg-14199820 Platelet adhesion
#msg-13292817 Pediatric ECMO
#msg-12714409 Retinal vein occlusion
#msg-11611213 VOD combo treatment with defibrotide
#msg-11609770 SPK transplantation
#msg-10969504 Recurrent thromboembolism risk
#msg-10321740 Aneurysm surgery

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.